Drugs / NPH
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00564018 | Sep 2006 → Feb 2009 | type 1 diabetes mellitus | University of Texas Southwestern Medical Center | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00564018 ↗ |
| Modality | Protein / enzyme biologic | “Currently, all children diagnosed with type 1 diabetes are placed on a combination of a long-acting insulin (such as insulins detemir or glargine) or a moderate-acting insulin...” NCT00564018 ↗ |